About Meredith Fisher
Form D filings for Violet Therapeutics in 2023 list Meredith Fisher as chief executive officer and director.
Meredith Fisher first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Meredith Fisher in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Meredith Fisher works with at each company, as listed on that company's latest Form D.
Violet Therapeutics, Inc. · Form D, May 5, 2023